1.     Tseng CH, Tseng CL, Chen HS, Chen PL, Huang CJ*. Clinical characteristics of neutropenic patients under anti-thyroid drug: Twelve year experience in a medical center. J Chin Med Assoc. 2023 Jul 20. (IF=3.0; R/C:75/167，Medicine, General & Internal)

2.     Tseng CH, Hu YA, Chen YT, Yu WC, Lin CC, Li SY. Beyond prevalence: significance and differential impact of echocardiographic abnormalities in dialysis patients. J Nephrol. 2024 Jun 4. (IF=2.7; R/C:36/126，Urology & Nephrology)

3.     Tseng CH, Huang WM, Chang HC, Yu WC, Cheng HM, Chiang CE, Chen CH, Sung SH. Tissue inhibitor of metalloproteinase (TIMP)-1 predicts failure of recovery of ejection fraction in acute heart failure with reduced ejection fraction. Open Heart. 2024 Sep 25;11(2):e002770. (IF=2.8; R/C:79/222，CARDIAC & CARDIOVASCULAR SYSTEMS)

4.    Chang, H. C., Tseng, C. H., Huang, W. M., Lee, C. W., Yu, W. C., Cheng, H. M., ... & Sung, S. H. (2024). Supranormal left ventricular ejection fraction, concentric remodeling, and long-term survival. JACC: Asia.